• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种佐剂为免疫刺激复合物(ISCOM)或黏膜淋巴组织趋化因子(mLT)的人诺如病毒样颗粒疫苗,在悉生猪疾病模型中可诱导细胞因子和抗体反应,并对同源GII.4型人诺如病毒产生保护作用。

A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.

作者信息

Souza Menira, Costantini Veronica, Azevedo Marli S P, Saif Linda J

机构信息

Food Animal Health Research Program, Ohio Agricultural Research and Development Center (OARDC), Department of Veterinary Preventive Medicine, The Ohio State University, 1680 Madison Avenue, Wooster, OH 44691, United States.

出版信息

Vaccine. 2007 Dec 5;25(50):8448-59. doi: 10.1016/j.vaccine.2007.09.040. Epub 2007 Oct 5.

DOI:10.1016/j.vaccine.2007.09.040
PMID:18022293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4094375/
Abstract

We inoculated gnotobiotic pigs orally/intranasally with human norovirus GII.4 HS66 strain virus-like particles (VLP) and immunostimulating complexes (ISCOM) or mutant E. coli LT toxin (mLT, R192G) as mucosal adjuvants, then assessed intestinal and systemic antibody and cytokine responses and homologous protection. Both vaccines induced high rates of seroconversion (100%) and coproconversion (75-100%). The VLP+mLT vaccine induced Th1/Th2 serum cytokines and cytokine secreting cells, whereas the VLP+ISCOM vaccine induced Th2 biased responses with significantly elevated IgM, IgA and IgG antibody-secreting cells in intestine. Nevertheless, both vaccines induced increased protection rates against viral shedding and diarrhea (75-100%) compared to controls; however, only 57% of controls shed virus.

摘要

我们经口/鼻内给无菌猪接种人诺如病毒GII.4 HS66株病毒样颗粒(VLP)以及作为黏膜佐剂的免疫刺激复合物(ISCOM)或突变型大肠杆菌LT毒素(mLT,R192G),然后评估肠道和全身抗体及细胞因子反应以及同源保护作用。两种疫苗均诱导了高血清转化率(100%)和粪便转化率(75 - 100%)。VLP + mLT疫苗诱导了Th1/Th2血清细胞因子和细胞因子分泌细胞,而VLP + ISCOM疫苗诱导了偏向Th2的反应,肠道中IgM、IgA和IgG抗体分泌细胞显著升高。然而,与对照组相比,两种疫苗均诱导了针对病毒排泄和腹泻的保护率增加(75 - 100%);不过,只有57%的对照组排出病毒。

相似文献

1
A human norovirus-like particle vaccine adjuvanted with ISCOM or mLT induces cytokine and antibody responses and protection to the homologous GII.4 human norovirus in a gnotobiotic pig disease model.一种佐剂为免疫刺激复合物(ISCOM)或黏膜淋巴组织趋化因子(mLT)的人诺如病毒样颗粒疫苗,在悉生猪疾病模型中可诱导细胞因子和抗体反应,并对同源GII.4型人诺如病毒产生保护作用。
Vaccine. 2007 Dec 5;25(50):8448-59. doi: 10.1016/j.vaccine.2007.09.040. Epub 2007 Oct 5.
2
Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.鼻内接种P颗粒疫苗为无菌猪提供了针对人GII.4诺如病毒腹泻的部分交叉变异保护。
J Virol. 2014 Sep 1;88(17):9728-43. doi: 10.1128/JVI.01249-14. Epub 2014 Jun 11.
3
Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.对无菌猪经鼻内给予含有突变型大肠杆菌不耐热毒素(LT-R192G)的2/6-轮状病毒样颗粒可诱导抗体分泌细胞反应,但不能诱导产生保护性免疫。
J Virol. 2000 Oct;74(19):8843-53. doi: 10.1128/jvi.74.19.8843-8853.2000.
4
Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calves.用不同佐剂对牛诺如病毒样颗粒的免疫反应及在无菌犊牛中的保护性分析
Vaccine. 2006 Jan 16;24(3):317-26. doi: 10.1016/j.vaccine.2005.07.071. Epub 2005 Aug 10.
5
Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.在无菌仔猪中,联合口服减毒的Wa人轮状病毒和鼻内接种含突变大肠杆菌不耐热毒素的Wa 2/6-VLPs所引发的保护性免疫和抗体分泌细胞反应。
J Virol. 2001 Oct;75(19):9229-38. doi: 10.1128/JVI.75.19.9229-9238.2001.
6
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.采用口服减毒人轮状病毒(HRV)进行初次免疫,并用含免疫刺激复合物(ISCOM)的鼻内VP2/6轮状病毒样颗粒(VLP)进行加强免疫的新的初免/加强疫苗策略后,无菌猪对人轮状病毒(HRV)的抗体反应。
Clin Exp Immunol. 2004 Mar;135(3):361-72. doi: 10.1111/j.1365-2249.2004.02395.x.
7
Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain).无菌猪感染人诺如病毒II.4基因组(HS66株)后的细胞因子和抗体反应。
J Virol. 2007 Sep;81(17):9183-92. doi: 10.1128/JVI.00558-07. Epub 2007 Jun 20.
8
Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus.无菌小牛感染人诺如病毒基因II.4-HS66株后的发病机制及免疫反应
J Virol. 2008 Feb;82(4):1777-86. doi: 10.1128/JVI.01347-07. Epub 2007 Nov 28.
9
Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses.在BALB/c小鼠中,将诺如病毒(基因组II型毒株)的重组病毒样颗粒与黏膜佐剂LT和LT(R192G)经鼻内和口服给药,可诱导特异性体液免疫和细胞Th1/Th2样免疫反应。
Vaccine. 2004 Mar 12;22(9-10):1079-86. doi: 10.1016/j.vaccine.2003.10.004.
10
High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen.高滴度的循环母体抗体可抑制由减毒轮状病毒初免和轮状病毒样颗粒免疫刺激复合物加强疫苗方案诱导的效应B细胞和记忆B细胞反应。
Clin Vaccine Immunol. 2006 Apr;13(4):475-85. doi: 10.1128/CVI.13.4.475-485.2006.

引用本文的文献

1
Virus Shedding and Diarrhea: A Review of Human Norovirus Genogroup II Infection in Gnotobiotic Pigs.病毒脱落与腹泻:人诺如病毒基因Ⅱ组感染无菌猪的研究综述。
Viruses. 2024 Sep 7;16(9):1432. doi: 10.3390/v16091432.
2
Current trends and new approaches for human norovirus replication in cell culture: a literature review.细胞培养中人类诺如病毒复制的当前趋势和新方法:文献综述。
Arch Virol. 2024 Mar 8;169(3):71. doi: 10.1007/s00705-024-05999-4.
3
Advances in Human Norovirus Vaccine Research.人类诺如病毒疫苗研究进展

本文引用的文献

1
Cytokine and antibody responses in gnotobiotic pigs after infection with human norovirus genogroup II.4 (HS66 strain).无菌猪感染人诺如病毒II.4基因组(HS66株)后的细胞因子和抗体反应。
J Virol. 2007 Sep;81(17):9183-92. doi: 10.1128/JVI.00558-07. Epub 2007 Jun 20.
2
A waterborne outbreak of gastroenteritis with multiple etiologies among resort island visitors and residents: Ohio, 2004.2004年俄亥俄州度假岛屿游客和居民中由多种病因引起的水源性肠胃炎暴发
Clin Infect Dis. 2007 Feb 15;44(4):506-12. doi: 10.1086/511043. Epub 2007 Jan 8.
3
Binding patterns of human norovirus-like particles to buccal and intestinal tissues of gnotobiotic pigs in relation to A/H histo-blood group antigen expression.
Vaccines (Basel). 2021 Jul 2;9(7):732. doi: 10.3390/vaccines9070732.
4
Evaluation of the 50% Infectious Dose of Human Norovirus Cin-2 in Gnotobiotic Pigs: A Comparison of Classical and Contemporary Methods for Endpoint Estimation.评价人诺如病毒 Cin-2 的 50%感染剂量:终点估计经典方法与现代方法的比较。
Viruses. 2020 Aug 28;12(9):955. doi: 10.3390/v12090955.
5
Virus-like particle-based vaccines for animal viral infections.用于动物病毒感染的基于病毒样颗粒的疫苗。
Inmunologia. 2013 Jul-Sep;32(3):102-116. doi: 10.1016/j.inmuno.2012.08.002. Epub 2012 Oct 26.
6
Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines.亚单位星状病毒疫苗的免疫原性和疗效评估
Vaccines (Basel). 2019 Aug 2;7(3):79. doi: 10.3390/vaccines7030079.
7
A Lactic Acid Bacteria (LAB)-Based Vaccine Candidate for Human Norovirus.基于乳酸菌的人类诺如病毒疫苗候选物。
Viruses. 2019 Mar 2;11(3):213. doi: 10.3390/v11030213.
8
Human Norovirus: Experimental Models of Infection.人类诺如病毒:感染的实验模型。
Viruses. 2019 Feb 12;11(2):151. doi: 10.3390/v11020151.
9
Norovirus vaccines: Correlates of protection, challenges and limitations.诺如病毒疫苗:保护的相关因素、挑战与局限
Hum Vaccin Immunother. 2016 Jul 2;12(7):1653-69. doi: 10.1080/21645515.2015.1125054. Epub 2016 Feb 2.
10
Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives.诺如病毒疫苗和潜在的抗诺如病毒药物:最新进展与未来展望。
Future Virol. 2015;10(7):899-913. doi: 10.2217/fvl.15.57.
人诺如病毒样颗粒与悉生猪口腔和肠道组织的结合模式与A/H组织血型抗原表达的关系
J Virol. 2007 Apr;81(7):3535-44. doi: 10.1128/JVI.01306-06. Epub 2007 Jan 10.
4
Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs.无菌仔猪中II型基因组人诺如病毒的发病机制
J Virol. 2006 Nov;80(21):10372-81. doi: 10.1128/JVI.00809-06.
5
Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.多价诺如病毒疫苗可诱导产生针对多种毒株的强效黏膜和全身性阻断抗体。
Vaccine. 2006 Jun 12;24(24):5220-34. doi: 10.1016/j.vaccine.2006.03.080. Epub 2006 Apr 18.
6
Cytokine responses in gnotobiotic pigs after infection with virulent or attenuated human rotavirus.无菌猪感染强毒株或减毒株人轮状病毒后的细胞因子反应
J Virol. 2006 Jan;80(1):372-82. doi: 10.1128/JVI.80.1.372-382.2006.
7
Development of a new microwell hybridization assay and an internal control RNA for the detection of porcine noroviruses and sapoviruses by reverse transcription-PCR.开发一种用于通过逆转录-聚合酶链反应检测猪诺如病毒和札幌病毒的新型微孔杂交检测法及内部对照RNA。
J Virol Methods. 2006 Mar;132(1-2):135-45. doi: 10.1016/j.jviromet.2005.10.003. Epub 2005 Nov 7.
8
Immune responses to bovine norovirus-like particles with various adjuvants and analysis of protection in gnotobiotic calves.用不同佐剂对牛诺如病毒样颗粒的免疫反应及在无菌犊牛中的保护性分析
Vaccine. 2006 Jan 16;24(3):317-26. doi: 10.1016/j.vaccine.2005.07.071. Epub 2005 Aug 10.
9
Cellular and humoral immunity following Snow Mountain virus challenge.感染雪山病毒后的细胞免疫和体液免疫。
J Virol. 2005 Mar;79(5):2900-9. doi: 10.1128/JVI.79.5.2900-2909.2005.
10
Norovirus transmission on cruise ship.诺如病毒在游轮上的传播。
Emerg Infect Dis. 2005 Jan;11(1):154-8. doi: 10.3201/eid1101.040434.